EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Valsartan
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms HFN-LIFE; LIFE
- 15 Nov 2021 Results random-effects model meta-analysis of three randomized controlled trials (PARADIGM-HF, PARADISE-MI and LIFE trial ) presented at the American Heart Association Scientific Sessions 2021
- 21 Oct 2020 Status changed from active, no longer recruiting to completed.
- 06 May 2020 Planned End Date changed from 21 Oct 2020 to 27 Oct 2020.